Geographical variation in Plasmodium vivax relapse

Geographical variation in Plasmodium vivax relapse

Show other versions (1)

Background: Plasmodium vivax has the widest geographic distribution of the human malaria parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in individuals and populations is complicated by its ability to relapse weeks to months after initial infection. Strains...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Battle, K, Karhunen, MS, Bhatt, S, Gething, P, Howes, R, Golding, N, Van Boeckel, T, Messina, J, Shanks, G, Smith, D, Baird, J, Hay, S
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	BioMed Central 2014

Eitemau Tebyg

Geographical variation in Plasmodium vivax relapse.
gan: Battle, K, et al.
Cyhoeddwyd: (2014)

Global epidemiology of Plasmodium vivax
gan: Howes, R, et al.
Cyhoeddwyd: (2016)

Global Epidemiology of Plasmodium vivax
gan: Howes, R, et al.
Cyhoeddwyd: (2016)

The global public health significance of Plasmodium vivax.
gan: Battle, K, et al.
Cyhoeddwyd: (2012)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
gan: Twohig, K, et al.
Cyhoeddwyd: (2019)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
gan: Battle, K, et al.
Cyhoeddwyd: (2015)

Plasmodium vivax transmission in Africa
gan: Howes, R, et al.
Cyhoeddwyd: (2015)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
gan: Baird, J, et al.
Cyhoeddwyd: (2018)

The international limits and population at risk of Plasmodium vivax transmission in 2009
gan: Guerra, C, et al.
Cyhoeddwyd: (2010)

Primaquine as anti-relapse therapy for Plasmodium vivax
gan: Baird, J
Cyhoeddwyd: (1998)

Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax.
gan: Gething, P, et al.
Cyhoeddwyd: (2011)

Plasmodium vivax Transmission in Africa.
gan: Rosalind E Howes, et al.
Cyhoeddwyd: (2015-11-01)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
gan: J. Kevin Baird, et al.
Cyhoeddwyd: (2018-01-01)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
gan: Katherine A Twohig, et al.
Cyhoeddwyd: (2019-01-01)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
gan: Baird, J
Cyhoeddwyd: (2018)

The epidemiology of Plasmodium vivax. Preface.
gan: Hay, S, et al.
Cyhoeddwyd: (2013)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
gan: Gething, P, et al.
Cyhoeddwyd: (2012)

The international limits and population at risk of Plasmodium vivax transmission in 2009.
gan: Carlos A Guerra, et al.
Cyhoeddwyd: (2010-08-01)

CAN THE SPATIAL DISTRIBUTION OF DUFFY NEGATIVITY EXPLAIN PLASMODIUM VIVAX ABSENCE IN AFRICA?
gan: Howes, R, et al.
Cyhoeddwyd: (2009)

The global burden of Plasmodium vivax malaria is obscure and insidious
gan: Battle, KE, et al.
Cyhoeddwyd: (2021)

Plasmodium vivax malaria endemicity in Indonesia in 2010
gan: Elyazar, I, et al.
Cyhoeddwyd: (2012)

Hypnozoite depletion in successive Plasmodium vivax relapses.
gan: Rintis Noviyanti, et al.
Cyhoeddwyd: (2022-07-01)

Modelling the global constraints of temperature on transmission of <it>Plasmodium falciparum </it>and <it>P. vivax </it>
gan: Patil Anand P, et al.
Cyhoeddwyd: (2011-05-01)

Attacking Plasmodium vivax
gan: Baird, J
Cyhoeddwyd: (2016)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
gan: Krudsood, S, et al.
Cyhoeddwyd: (2008)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
gan: Cecilia Giraldo, et al.
Cyhoeddwyd: (1991-01-01)

Determinants of relapse periodicity in <it>Plasmodium vivax </it>malaria
gan: White Nicholas J
Cyhoeddwyd: (2011-10-01)

Management of relapsing Plasmodium vivax malaria
gan: Chu, C, et al.
Cyhoeddwyd: (2016)

The burden of Plasmodium vivax malaria
gan: Battle, K
Cyhoeddwyd: (2015)

Neglect of Plasmodium vivax malaria.
gan: Baird, J
Cyhoeddwyd: (2007)

Chloroquine resistance in Plasmodium vivax.
gan: Baird, J
Cyhoeddwyd: (2004)

Defining the geographical range of the Plasmodium knowlesi reservoir.
gan: Moyes, C, et al.
Cyhoeddwyd: (2014)

Population heterogeneity in Plasmodium vivax relapse risk.
gan: Eva Stadler, et al.
Cyhoeddwyd: (2022-12-01)

Estimating geographical variation in the risk of zoonotic Plasmodium knowlesi infection in countries eliminating malaria
gan: Shearer, FM, et al.
Cyhoeddwyd: (2016)

Pernicious and threatening Plasmodium vivax as reality.
gan: Baird, J
Cyhoeddwyd: (2014)

Resistance to therapies for infection by Plasmodium vivax.
gan: Baird, J
Cyhoeddwyd: (2009)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
gan: Watson, JA, et al.
Cyhoeddwyd: (2021)

Determinants of relapse periodicity in Plasmodium vivax malaria.
gan: White, N
Cyhoeddwyd: (2011)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
gan: James A Watson, et al.
Cyhoeddwyd: (2021-05-01)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
gan: Peter W Gething, et al.
Cyhoeddwyd: (2012-01-01)